Yesterday the Food and Drug Administration (FDA) approved Spravato (esketamine) nasal spray to be us...
Intranasal esketamine—a derivative of ketamine—appears to rapidly reduce symptoms of depression, inc...
In patients with treatment-resistant depression who responded to intranasal esketamine plus an antid...
